Hollsteen
← F5

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 FY2016: $433M · 10-Q 0001048695-16-000026 filed Jan 27, 2016Cash and equivalents · Q2 FY2016: $398M · 10-Q 0001048695-16-000035 filed Apr 27, 2016Cash and equivalents · Q3 FY2016: $430M · 10-Q 0001048695-16-000041 filed Jul 27, 2016Cash and equivalents · Q4 FY2016: $515M · 10-K 0001048695-16-000049 filed Nov 4, 2016Cash and equivalents · Q1 FY2017: $573M · 10-Q 0001048695-17-000008 filed Feb 1, 2017Cash and equivalents · Q2 FY2017: $656M · 10-Q 0001048695-17-000016 filed May 10, 2017Cash and equivalents · Q3 FY2017: $691M · 10-Q 0001048695-17-000022 filed Aug 2, 2017Cash and equivalents · Q4 FY2017: $673M · 10-K 0001048695-17-000028 filed Nov 3, 2017Cash and equivalents · Q1 FY2018: $612M · 10-Q 0001048695-18-000005 filed Feb 2, 2018Cash and equivalents · Q2 FY2018: $596M · 10-Q 0001048695-18-000017 filed May 2, 2018Cash and equivalents · Q3 FY2018: $599M · 10-Q 0001048695-18-000025 filed Aug 1, 2018Cash and equivalents · Q4 FY2018: $425M · 10-K 0001048695-18-000031 filed Nov 21, 2018Cash and equivalents · Q1 FY2019: $480M · 10-Q 0001048695-19-000008 filed Feb 1, 2019Cash and equivalents · Q2 FY2019: $727M · 10-Q 0001048695-19-000014 filed May 3, 2019Cash and equivalents · Q3 FY2019: $688M · 10-Q 0001048695-19-000030 filed Aug 2, 2019Cash and equivalents · Q4 FY2019: $599M · 10-K 0001048695-19-000034 filed Nov 15, 2019Cash and equivalents · Q1 FY2020: $735M · 10-Q 0001048695-20-000012 filed Feb 5, 2020Cash and equivalents · Q2 FY2020: $573M · 10-Q 0001048695-20-000027 filed May 6, 2020Cash and equivalents · Q3 FY2020: $714M · 10-Q 0001048695-20-000035 filed Aug 5, 2020Cash and equivalents · Q4 FY2020: $850M · 10-K 0001048695-20-000041 filed Nov 19, 2020Cash and equivalents · Q1 FY2021: $1.0B · 10-Q 0001048695-21-000009 filed Feb 5, 2021Cash and equivalents · Q2 FY2021: $532M · 10-Q 0001048695-21-000021 filed May 6, 2021Cash and equivalents · Q3 FY2021: $584M · 10-Q 0001048695-21-000033 filed Aug 5, 2021Cash and equivalents · Q4 FY2021: $581M · 10-K 0001048695-21-000044 filed Nov 16, 2021Cash and equivalents · Q1 FY2022: $512M · 10-Q 0001048695-22-000007 filed Feb 4, 2022Cash and equivalents · Q2 FY2022: $587M · 10-Q 0001048695-22-000015 filed May 6, 2022Cash and equivalents · Q3 FY2022: $542M · 10-Q 0001048695-22-000025 filed Aug 5, 2022Cash and equivalents · Q4 FY2022: $758M · 10-K 0001048695-22-000033 filed Nov 15, 2022Cash and equivalents · Q1 FY2023: $606M · 10-Q 0001048695-23-000011 filed Feb 3, 2023Cash and equivalents · Q2 FY2023: $735M · 10-Q 0001048695-23-000018 filed May 5, 2023Cash and equivalents · Q3 FY2023: $677M · 10-Q 0001048695-23-000030 filed Aug 4, 2023Cash and equivalents · Q4 FY2023: $797M · 10-K 0001048695-23-000039 filed Nov 14, 2023Cash and equivalents · Q1 FY2024: $823M · 10-Q 0001048695-24-000012 filed Feb 5, 2024Cash and equivalents · Q2 FY2024: $903M · 10-Q 0001048695-24-000079 filed May 6, 2024Cash and equivalents · Q3 FY2024: $935M · 10-Q 0001048695-24-000125 filed Aug 6, 2024Cash and equivalents · Q4 FY2024: $1.1B · 10-K 0001048695-24-000185 filed Nov 18, 2024Cash and equivalents · Q1 FY2025: $1.2B · 10-Q 0001048695-25-000026 filed Feb 7, 2025Cash and equivalents · Q2 FY2025: $1.3B · 10-Q 0001048695-25-000091 filed May 6, 2025Cash and equivalents · Q3 FY2025: $1.4B · 10-Q 0001048695-25-000129 filed Aug 6, 2025Cash and equivalents · Q4 FY2025: $1.3B · 10-K 0001048695-25-000157 filed Nov 25, 2025Cash and equivalents · Q1 FY2026: $1.2B · 10-Q 0001048695-26-000023 filed Feb 5, 2026Cash and equivalents · Q2 FY2026: $1.4B · 10-Q 0001048695-26-000051 filed May 5, 2026Cash and equivalents · Q3 FY2026: $1.6B · 10-Q 0001048695-26-000067 filed Aug 6, 20265321,606433Q1 FY2016Q3 FY2026Q2 FY2021
$MCash and equivalents · Q2 FY2020: $573M · 10-Q 0001048695-20-000027 filed May 6, 2020Cash and equivalents · Q3 FY2020: $714M · 10-Q 0001048695-20-000035 filed Aug 5, 2020Cash and equivalents · Q4 FY2020: $850M · 10-K 0001048695-20-000041 filed Nov 19, 2020Cash and equivalents · Q1 FY2021: $1.0B · 10-Q 0001048695-21-000009 filed Feb 5, 2021Cash and equivalents · Q2 FY2021: $532M · 10-Q 0001048695-21-000021 filed May 6, 2021Cash and equivalents · Q3 FY2021: $584M · 10-Q 0001048695-21-000033 filed Aug 5, 2021Cash and equivalents · Q4 FY2021: $581M · 10-K 0001048695-21-000044 filed Nov 16, 2021Cash and equivalents · Q1 FY2022: $512M · 10-Q 0001048695-22-000007 filed Feb 4, 20225325125731,027Q2 FY2020Q1 FY2022Q2 FY2021
Q2 FY2021
532$M
All values (43)
PeriodValue ($M)Status
Q3 FY20261,606reported
Q2 FY20261,443reported
Q1 FY20261,200reported
Q4 FY20251,344reported
Q3 FY20251,427reported
Q2 FY20251,259reported
Q1 FY20251,151reported
Q4 FY20241,075reported
Q3 FY2024935reported
Q2 FY2024903reported
Q1 FY2024823reported
Q4 FY2023797reported
Q3 FY2023677reported
Q2 FY2023735reported
Q1 FY2023606reported
Q4 FY2022758reported
Q3 FY2022542reported
Q2 FY2022587reported
Q1 FY2022512reported
Q4 FY2021581reported
Q3 FY2021584reported
Q2 FY2021532reported
Q1 FY20211,027reported
Q4 FY2020850reported
Q3 FY2020714reported
Q2 FY2020573reported
Q1 FY2020735reported
Q4 FY2019599reported
Q3 FY2019688reported
Q2 FY2019727reported
Q1 FY2019480reported
Q4 FY2018425reported
Q3 FY2018599reported
Q2 FY2018596reported
Q1 FY2018612reported
Q4 FY2017673reported
Q3 FY2017691reported
Q2 FY2017656reported
Q1 FY2017573reported
Q4 FY2016515reported
Q3 FY2016430reported
Q2 FY2016398reported
Q1 FY2016433reported

CSV with all sources · Technical ID: cash

More metrics for F5

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$532M
Period
Q2 FY2021, ended Mar 31, 2021 · as of Mar 31, 2021 (balance as of date, not a sum)
Source
10-Q, filed May 6, 2021 · 0001048695-21-000021
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$532MMay 6, 202110-Q 0001048695-21-000021reported · confidence 1. · current